Related Experiment Video
Updated: May 21, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Drug-induced atrial fibrillation
Juan Tamargo1, Ricardo Caballero, Eva Delpón
1Department of Pharmacology, School of Medicine, Universidad Complutense, 28040 Madrid, Spain. jtamargo@med.ucm.es
Expert Opinion on Drug Safety
|June 26, 2012
Summary
Drug-induced atrial fibrillation (AF) is a growing concern, often overlooked despite its potential to cause serious cardiac events. Increased awareness among healthcare providers and patients is crucial for managing this adverse drug effect.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia linked to significant morbidity and mortality.
- Numerous medications can precipitate AF, yet drug-induced AF (DIAF) is often underrecognized.
- This review aims to highlight DIAF as a critical adverse drug effect.
Purpose of the Study:
- To review published cases of drug-induced atrial fibrillation (DIAF).
- To increase awareness of DIAF among healthcare professionals and patients.
- To discuss the implications and management of DIAF.
Main Methods:
- A comprehensive literature search was conducted using PubMed/Medline.
- The review encompassed published reports of DIAF from January 1974 to December 2011.
- Lateral references were also utilized to identify relevant studies.
Main Results:
- DIAF is frequently paroxysmal and self-limiting.
- Persistent AF may necessitate cardioversion to restore normal heart rhythm.
- The true incidence and clinical impact of DIAF remain largely unknown due to its transient nature and lack of awareness.
Conclusions:
- DIAF is an emerging issue, with common drugs capable of inducing this arrhythmia.
- The elderly and patients with comorbidities are at higher risk.
- Enhanced physician understanding, interdisciplinary collaboration, and patient education are vital for addressing DIAF.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:28Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...